Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconASNDAscendis Pharma A/S$7.87bnn/an/a
us flag iconPCVXVaxcyte$7.65bnn/an/a
us flag iconCERECerevel Therapeutics Holdings$7.42bnn/an/a
us flag iconLEGNLegend Biotech$7.29bnn/an/a
us flag iconVKTXViking Therapeutics$6.87bnn/an/a
us flag iconBPMCBlueprint Medicines$6.61bnn/an/a
us flag iconRETAReata Pharmaceuticals$6.52bnn/an/a
us flag iconRVMDRevolution Medicines$6.32bnn/an/a
us flag iconEXELExelixis$6.32bn29.79n/a
us flag iconSMMTSummit Therapeutics$6.10bnn/an/a
us flag iconHALOHalozyme Therapeutics$5.64bn18.21n/a
us flag iconCYTKCytokinetics$5.56bnn/an/a
us flag iconISEEIVERIC bio$5.51bnn/an/a
us flag iconIONSIonis Pharmaceuticals$5.48bnn/an/a
us flag iconMDGLMadrigal Pharmaceuticals$5.03bnn/an/a
us flag iconKRYSKrystal Biotech$4.57bnn/an/a
us flag iconCRSPCrispr Therapeutics AG$4.56bnn/an/a
us flag iconSYNHSyneos Health$4.46bn28.55n/a
us flag iconALPNAlpine Immune Sciences$4.46bnn/an/a
us flag iconIBRXImmunitybio$4.44bnn/an/a